1. Home
  2. WAFU vs OGEN Comparison

WAFU vs OGEN Comparison

Compare WAFU & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wah Fu Education Group Limited

WAFU

Wah Fu Education Group Limited

N/A

Current Price

$1.68

Market Cap

7.4M

Sector

Real Estate

ML Signal

N/A

Logo Oragenics Inc.

OGEN

Oragenics Inc.

N/A

Current Price

$0.62

Market Cap

2.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAFU
OGEN
Founded
1999
1996
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
2.8M
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
WAFU
OGEN
Price
$1.68
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.3K
46.4K
Earning Date
07-31-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.36
$0.50
52 Week High
$2.17
$4.85

Technical Indicators

Market Signals
Indicator
WAFU
OGEN
Relative Strength Index (RSI) 48.95 56.71
Support Level $1.57 $0.61
Resistance Level $1.77 $0.65
Average True Range (ATR) 0.11 0.03
MACD 0.00 0.00
Stochastic Oscillator 22.92 74.14

Price Performance

Historical Comparison
WAFU
OGEN

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

About OGEN Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

Share on Social Networks: